SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community anticipates potential ETF approvals and discusses its ability to break the $3 resistance level; some see the government shutdown as a potential catalyst. Despite positive sentiment and news, some traders express frustration with XRP's price action compared to other cryptocurrencies. The community debates its utility, future price predictions, and the implications of recent Ripple leadership changes.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI (RZLV) is trending as the community discusses its recent performance following earnings, with debates focusing on revenue projections and the impact of short reports. Some traders believe the stock is poised for a short squeeze, citing high short interest and positive analyst ratings, while others express concerns about the company's financials and question its AI capabilities. The community is closely monitoring price movements and potential catalysts, including upcoming news related to crypto payments.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending as investors discuss the recent Evercore downgrade and the completion of the sale of its European ORLADEYO business, leading to mixed reactions. Community sentiment is divided, with some expressing frustration over the stock's performance and others highlighting the company's fundamentals and potential for a buyout or share buyback. The conversation includes speculation about future acquisitions, pipeline developments, and the impact of competition in the HAE market.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

BKKT is surging amid a broader crypto rally and optimism surrounding its strategic restructuring into a pure-play digital asset platform. Traders are actively discussing its potential for a short squeeze and are encouraged by a new board appointment. Bullish sentiment is building, with community members speculating about potential partnerships and expansion into foreign markets.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is trending downwards as the community debates the impact of reduced reliance on Reddit data by ChatGPT and other AI models. Some traders believe the stock is oversold and due for a rebound, while others express concerns about its long-term value and potential for further decline. Community members are closely watching key support levels and discussing possible manipulation by hedge funds.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending amid community enthusiasm and discussions around its cultural significance within the crypto space. The community highlights Weedcoin's focus on building value and promoting a culture-driven movement. Some users are contrasting it with other meme coins, while many express excitement about its potential.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors discuss a potential short squeeze and analyst target of $50, with some community members anticipating a significant price increase. The stock's movement is attributed to renewed investor confidence and speculation around positive news or a possible buyout. Community members are closely watching resistance levels and expressing optimism about the stock's long-term potential.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending due to Berkshire Hathaway's acquisition of its OxyChem unit, sparking debates about the deal's implications and $OXY's future strategy. Community chatter includes speculation about share buybacks and whether the stock is undervalued following the news. Some traders express frustration with the stock's performance and question Warren Buffett's continued investment in the company.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's Q3 delivery numbers beat estimates, but the stock is down, sparking debate on whether this was a "sell the news" event or a sign of concerns about future growth and the end of EV tax credits; the community is actively discussing potential support levels and the impact of Elon Musk's actions on the stock.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is trending amid discussion of a potential short squeeze and recent insider buying activity, signaling confidence in the company's future. Community members are also highlighting the gene therapy sector's overall positive momentum and anticipating updates on CRSP's pipeline, particularly regarding its CTX112 data. Some investors are looking for CRSP to break key resistance levels and reach higher price targets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hormel Foods Bets on Transform and Modernize to Drive Profitability

HRL's Transform and Modernize initiative drives supply-chain upgrades, brand refreshes and stronger profitability targets for 2025.

Tyson Foods (TSN) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Tyson Foods (TSN) stood at $54.46, denoting a +1.13% move from the preceding trading day.

Tyson Foods' Brand Strength & Efficiency to Strengthen Market Leadership

TSN drives growth through a strong protein portfolio, brand innovation and a focus on operational excellence.

Why Tyson Foods (TSN) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Tyson (TSN) Up 3.2% Since Last Earnings Report: Can It Continue?

Tyson (TSN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Will Tyson Foods' Protein Leadership and Innovation Fuel Growth?

TSN leverages its diverse protein portfolio, iconic brands and innovation to strengthen growth and resilience.

Why Tyson Foods (TSN) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Tyson Foods (TSN) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Consumer stocks rose last week, with discretionary shares&nbsp;outperforming staples as investors&nbsp;positioned themselves ahead of Tuesday's inflation report.The Consumer Discretionary Select Sector SPDR Fund (XLY) rose 3.6%, nearly recovering losses from the week prior. The Consumer Staples Select Sector SPDR Fund (XLP) rose 2.9%, its biggest weekly gain since October 2023.Here are the top gainers in the sector:&nbsp;Expedia Group (weekly gain 9.7%)A major part of the lift came on Friday, after the online travel company's quarterly report. Expedia&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/expedia-stock-pops-on-outlook-boost-as-business-travel-rebounds-but-ceo-says-lower-end-of-market-in-wait-and-see-mode/chrVUztRd3p">beat expectations</a> for revenue and profit for its second quarter, and the company raised its annual outlook for revenue and gross booking growth.Following the report, Bernstein raised its price target on the stock by a wide margin, from $162 to $215, noting the strength in the company's business travel segment.&nbsp;Monster Beverage (weekly gain 9.6%)The energy drink was also the beneficiary of an end-of-the-week rally. Shares gained 6.4% on Friday after reporting higher-than-expected quarterly revenue and profit.The energy drinks segment has garnered particular investor interest lately; CEO Hilton Schlosberg&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/monster-beverages-stock-heads-for-best-day-in-over-2-years-after-upbeat-q2-retail-traders-turn-extremely-bullish/chrnEfXRdE0">noted</a> that energy drinks are being purchased by an increasing number of households, with per capita consumption also on the rise.&nbsp;Tyson Foods (weekly gain 8.6%)The meat producer is on a winning streak, with shares rising for six consecutive sessions. Tyson Foods, on Monday, beat quarterly revenue and profit expectations, and raised its sales growth forecast. It now stands at 2% to 3%, compared to its previous estimate of 1%, driven partly by the strength in pork and chicken meat sales. For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-faces-growth-challenges-as-staff-give-thumbs-down-to-management-efforts-report/chruFqaRdIR">Target Faces Growth Challenges As Staff Give Thumbs Down To Management Efforts: Report</a>

People shop at a grocery store in Brooklyn on July 11, 2024 in New York City. (Photo by Spencer Platt/Getty Images)

Expedia, Monster Beverage, Tyson Foods: Strong Earnings Drive Best In Sector Gains Last Week

Discretionary stocks outpaced staples last week, as investors positioned themselves ahead of Tuesday's inflation report.

Equity

Discretionary stocks outpaced staples last week, as investors positioned themselves ahead of Tuesday's inflation report.


 Company News for Aug 5, 2025

Tyson Foods, Inc. engages in the processing of prepared food and other related products. It operates through the following segments: Beef, Pork, Chicken, and Prepared Foods. The Beef segment includes processing live fed cattle and fabricating dressed beef carcasses into primal and sub-primal meat cuts and case-ready products. The Pork segment focuses on live market hogs and fabricating pork carcasses. The Chicken segment is involved in raising and processing live chickens into fresh, frozen, and value-added chicken products, and sales from specialty products. The Prepared Foods segment manufactures and markets food products and offers logistic operations to move products through the supply chain. The company was founded by John W. Tyson in 1935 and is headquartered in Springdale, AR.

Tyson Foods, Inc. - Ordinary Shares - Class A

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.89	--	--	N/A
Q3 '25	$0.80	$0.91	13.51%	BEAT
Q2 '25	$0.83	$0.92	10.77%	BEAT
Q1 '25	$0.90	$1.14	26.56%	BEAT
Q4 '24	$0.72	$0.92	28.53%	BEAT

TSN
Tyson Foods, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TSN News

TSN Tyson Foods, Inc.